CyFluATG in Lower Risk MDS
NCT06098326
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndromes
Interventions
DRUG:
cyclophosphamide, fludarabine, and antithymocyte globulin
Sponsor
Asan Medical Center